Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
public offering
Odysight.ai Announces the Pricing of $21.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
10 févr. 2025 20h00 HE
|
Odysight.ai Inc.
Odysight.ai common stock to begin trading on Nasdaq Tuesday, February 11, 2025, under the symbol “ODYS” OMER, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq:...
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
04 févr. 2025 16h31 HE
|
Annovis Bio, Inc.
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Evaxion announces closing of $10.8 million public offering
31 janv. 2025 16h05 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, January 31, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the...
Evaxion announces pricing of $10.8 million public offering
30 janv. 2025 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, January 30, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the...
Giftify, Inc. Announces Pricing of $600,000 Public Offering of Common Stock with No Warrants
15 janv. 2025 09h30 HE
|
Giftify, Inc.
SCHAUMBURG, IL, Jan. 15, 2025 (GLOBE NEWSWIRE) -- : Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of leading digital platforms, CardCash.com and Restaurant.com, with a focus...
uniQure Announces Pricing of its Public Offering
08 janv. 2025 07h05 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
uniQure Announces Proposed Public Offering
07 janv. 2025 16h49 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Algorhythm Holdings, Inc. Announces Pricing of $9.5 Million Public Offering
05 déc. 2024 08h45 HE
|
Algorhythm Holdings, Inc.
Fort Lauderdale, FL, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm” or the “Company”) (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company,...
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25 nov. 2024 16h00 HE
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
14 nov. 2024 16h30 HE
|
GlucoTrack, Inc.
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for...